Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]

Takehiko Mori, Yoshinobu Aisa, Tomonori Nakazato, Yasuo Ikeda, Shinichiro Okamoto

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]'. Together they form a unique fingerprint.